Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship*

(2014) Nilesh B. Bhatt et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of Inhibitory Effects of Caffeic acid and Quercetin on Human Liver Cytochrome P450 Activities

(2014) Himanshu Rastogi et al.   PHYTOTHERAPY RESEARCH

Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents

(2014) Vamshi K. Manda et al.   Frontiers in Pharmacology

The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study

(2013) Ane Djuv et al.   BMC Complementary and Alternative Medicine

Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic

(2013) Lauro Ferreira da Silva Pinto Neto et al.   Brazilian Journal of Infectious Diseases

Phytochemical constituents, antioxidant properties and p-coumaric acid analysis in some seagrasses

(2013) Rengasamy Ragupathi Raja Kannan et al.   FOOD RESEARCH INTERNATIONAL

Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance

(2013) Ulrich M. Zanger et al.   Frontiers in Genetics

Herb-Drug Interactions and Mechanistic and Clinical Considerations

(2012) Xiao-Wu Chen et al.   CURRENT DRUG METABOLISM

Herbal Medicines for the Prevention and Treatment of Alzheimer's Disease

(2012) Hyo Geun Kim et al.   CURRENT PHARMACEUTICAL DESIGN

Metabolome Classification of CommercialHypericum perforatum(St. John's Wort) Preparations via UPLC-qTOF-MS and Chemometrics

(2012) Mohamed Farag et al.   PLANTA MEDICA

Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania

(2012) Sabina Mugusi et al.   PLoS One

Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain function

(2012) David O. Kennedy et al.   Advances in Nutrition

Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies

(2011) X.-W. Chen et al.   CURRENT MEDICINAL CHEMISTRY

ADME Properties of Herbal Medicines in Humans: Evidence, Challenges and Strategies

(2011) Shu-Ming He et al.   CURRENT PHARMACEUTICAL DESIGN

A Refined Cytochrome P450 IC50 Shift Assay for Reliably Identifying CYP3A Time-Dependent Inhibitors

(2011) P. Li et al.   DRUG METABOLISM AND DISPOSITION

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

(2011) G Yimer et al.   PHARMACOGENOMICS JOURNAL

Dyslipidemia and lipid management in HIV-infected patients

(2011) Janet Lo   Current Opinion in Endocrinology Diabetes and Obesity

Biological analysis of herbal medicines used for the treatment of liver diseases

(2010) Chao-Feng Chien et al.   BIOMEDICAL CHROMATOGRAPHY

Liver Disease in the HIV–Infected Individual

(2010) Jennifer C. Price et al.   Clinical Gastroenterology and Hepatology

Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy

(2010) Thomas Efferth et al.   CURRENT DRUG TARGETS

Predicting Drug–Drug Interactions: An FDA Perspective

(2009) Lei Zhang et al.   AAPS Journal

Substrate Specificity, Regulation, and Polymorphism of Human Cytochrome P450 2B6

(2009) Sui-Lin Mo et al.   CURRENT DRUG METABOLISM

The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

(2009) S. W. Grimm et al.   DRUG METABOLISM AND DISPOSITION

Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans

(2009) David W. Haas et al.   JOURNAL OF INFECTIOUS DISEASES

CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme

(2008) Hongbing Wang et al.   CURRENT DRUG METABOLISM

New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

(2008) Shiew-Mei Huang et al.   JOURNAL OF CLINICAL PHARMACOLOGY